Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 37988-38-8 | MDL No. : | MFCD00209259 |
Formula : | C8H11NO | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | LUZJNRNNOOBBDY-UHFFFAOYSA-N |
M.W : | 137.18 | Pubchem ID : | 2779146 |
Synonyms : |
|
Num. heavy atoms : | 10 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.38 |
Num. rotatable bonds : | 1 |
Num. H-bond acceptors : | 2.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 39.86 |
TPSA : | 33.12 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.72 cm/s |
Log Po/w (iLOGP) : | 1.63 |
Log Po/w (XLOGP3) : | 0.59 |
Log Po/w (WLOGP) : | 1.2 |
Log Po/w (MLOGP) : | 0.55 |
Log Po/w (SILICOS-IT) : | 1.5 |
Consensus Log Po/w : | 1.09 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -1.44 |
Solubility : | 4.98 mg/ml ; 0.0363 mol/l |
Class : | Very soluble |
Log S (Ali) : | -0.86 |
Solubility : | 19.0 mg/ml ; 0.138 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -2.24 |
Solubility : | 0.784 mg/ml ; 0.00571 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.33 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
97% | at -78 - 20℃; for 1.25 h; | [00151] Example 8. Synthesis of 2-(pyridin-2-yl)propan-2-ol (PyPrOH) and I -phenyl- 1 - (pyridin-2-yl)ethanol (PPE). The appropriate ketone Py(CQ)(L) (8.3 mmol) was dissolved in dry diethyl ether (100 mL) in an oven-dried 250 mL schlenk flask. This was cooled to -78° C and MeLi (12.9 mL of a 1.6M solution) was added slowly over 15 minutes. The resulting yellow solution was stirred at -78° C for 1 hour, and was then warmed to ambient temperature. Next, saturated NH4C1 (aq) (30 mL) was added to quench the reaction, and the resulting solution was extracted with EtOAc (3 x 75 mL), dried over Na2S04, and the solvent evaporated in vacuo. The crude product was purified via flash chromatography (Si02, 1 : 1 EtOAc:CH2Cl2 for L=Me, 1 :3 EtOAc:CH2Cl2 for L=Ph) to yield a light yellow oil. PyPrOH was obtained (yield: 55percent). PyPrOH: 1H NMR NMR (CDCL, 300 MHz): δ 8.52 (d of m, J= 4.8 Hz, 1 H); 7.71 (t of m, J = 7.8 Hz, 1 H): 7.38 (d of m, J= 8.1 Hz, ): 7.21 (t of m, J= 6.2 Hz, i l l ): 5.08 (s, 1H); 1.54 (s, 6H). PPE was obtained (yield: 97percent). 1H NMR (CDC13, 300 MHz): δ 8.52 (d of m, J= 5.1 Hz, 1 H): 7.65 (t of d, J= 7.8 Hz, 1.8 Hz, 1 H); 7.48 (m, 2H); 7.31 (m, 3H); 7.17- 7.26 (m, 2H); 5.85 (s, 1H); 1.94 (s, 3H). |
[ 213248-46-5 ]
1-(Pyridin-2-yl)propane-1,3-diol
Similarity: 0.90
[ 41598-71-4 ]
6,7-Dihydro-5H-cyclopenta[b]pyridin-7-ol
Similarity: 0.86
[ 477252-20-3 ]
2-(4-Bromopyridin-2-yl)propan-2-ol
Similarity: 0.82
[ 213248-46-5 ]
1-(Pyridin-2-yl)propane-1,3-diol
Similarity: 0.90
[ 477252-20-3 ]
2-(4-Bromopyridin-2-yl)propan-2-ol
Similarity: 0.82
[ 638218-78-7 ]
2-(6-Bromopyridin-2-yl)propan-2-ol
Similarity: 0.82